Manufacturer record
Macleods Pharmaceuticals Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
18 batches manufactured by Macleods Pharmaceuticals Ltd (Daman & Diu) were declared Not of Standard Quality between October 2019 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 16251875A, Thyroxine Sodium Tablets IP (exp Nov 2027). LUCKNOW, Uttar Pradesh (state lab) found it not of standard quality: The sample does not conform to IP in respect of Dissolution. Listed in the September 2026 alert.
Records by type
18 records linked to Macleods Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Thyroxine Sodium Tablets IP | Batch 16251875AMfg Dec 2025 · Exp Nov 2027 | The sample does not conform to IP in respect of DissolutionDissolution | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Thyroxine Sodium Tablets IP | Batch H26MAB011Mfg Jan 2026 · Exp Dec 2027 | The sample does not conform to IP with respect to DissolutionDissolution | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Thyroxine Sodium Tablets IP | Batch 16251692AMfg Nov 2025 · Exp Oct 2027 | The sample does not conform to IP with respect to dissolutionDissolution | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Ferrous Ascorbate, Folic Acid and Cyanocobalamin Suspension | Batch 18260226AMfg Jan 2026 · Exp Dec 2028 | Identity test negative for Folic Acid & content of Elemental IronOther | Lucknow LabState lab | Jul 2026 |
| Ferrous Assorbate, Folic Acid and Cyanocobalamin Suspension | Batch 18260226AMfg Jan 2026 · Exp Dec 2028 | 01. ASSAY OF FOLIC ACID I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab | Jul 2026 |
| Levosalbutamol Sulphate Ambroxol Hydrochloride and Guaiphenesin Expectorant. | Batch 18253692AMfg Sep 2025 · Exp Aug 2027 | Description as per Schedule V of Drugs and Cosmetics act 1940 & Rules 1945 thereunder.Description | DTL, Bengaluru, KarnatakaState lab | Jun 2026 |
| Ceftriaxone Injection I.P. | Batch 18251528AMfg Apr 2025 · Exp Mar 2027 | The sample does not conform to I.P with respect to the tests of Appearance of solution, Clarity of Solution and Particulate MatterParticulate matter | CDL, KolkataCDSCO lab | May 2026 |
| Levosalbutamol Sulphate Ambroxol Hydrochloride and Guaiphenesin Expectorant | Batch 18251296AMfg Mar 2025 · Exp Feb 2027 | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab | Mar 2026 |
| Clobetasol Propionate Neomycin Sulphate and Miconazole Nitrate Cream | Batch 18241408AMfg Jul 2024 · Exp Jun 2026 | SpouriosOther | SDTL Raipur ChhattisgarhState lab | Sep 2025 |
| Tranexamic Acid Tablets IP (Trenaxa 500) | Batch 18242021AMfg Aug 2024 · Exp Jul 2027 | Spurious Identification and Assay of Tranexamic AcidAssay | CDL, KolkataCDSCO lab | May 2025 |
| Thyroxine Sodium tablets IP (THYROX-25) | Batch 16240148DMfg May 2024 · Exp Apr 2026 | DissolutionDissolution | CDL KolkataCDSCO lab | Dec 2024 |
| Glucosamine Sulfate Potassium Chloride MSM and Diacerein Tablets (Orcerin GM) | Batch KOO2207AMfg May 2022 · Exp Apr 2025 | DescriptionDescription | CDL KolkataCDSCO lab | Oct 2024 |
| Deflazacort Tablets (Defcort 6 Tablets) | Batch GDB23041AMfg May 2023 · Exp Apr 2026 | Test of Identification and Assay of DeflazacortAssay | Not applicableState lab | Aug 2024 |
| Thyroxine Sodium Tablets I.P. (THYROX- 75) | Batch MTC2338AMfg Apr 2023 · Exp Mar 2025 | DissolutionDissolution | CDL KolkataCDSCO lab | Apr 2024 |
| Acenomac 1 (Nicoumalone Tablets IP) | Batch FNU02202AMfg Nov 2022 · Exp Oct 2024 | Related substancesRelated substances | CDL KolkataCDSCO lab | Jun 2023 |
| Calcitriol and Calcium Capsules (BIO-D3 PLUS CAPSULES) | Batch ACB2008AMfg Sep 2020 · Exp Aug 2023 | Assay of CalcitriolAssay | RDTL ChandigarhState lab | Mar 2022 |
| Cycloserine Capsules USP 250 mg | Batch ECB5836AMfg Jul 2018 · Exp Jun 2021 | Condensation Products and AssayAssay | CDTL MumbaiCDSCO lab | Nov 2019 |
| Clobetasol Propionate, Neomycin Sulphate and Miconazole Nitrate Cream (PANDERM ++CREAM) | Batch PCF901AMfg Feb 2019 · Exp Jan 2021 | IdentificationIdentification | RDTL ChandigarhState lab | Oct 2019 |
Batches reported as suspected spurious under this label
CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.
| Product | Batch | Reported by | Firm's reply | Alert |
|---|---|---|---|---|
| Deflazacort Tablets 6 mg Defcort 6 | 13240334A | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Dec 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.